In participants with APOE ε4 homozygosis, the overall frequencies of AD pathological diagnosis were 86% among participants with dementia, 67% in those with questionable dementia, and 38% among participants with normal cognition (Figure S6). This evidence concerns the gene APOE and Alzheimer disease.